|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 37964 |
FusionGeneSummary for THAP7_A4GALT |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: THAP7_A4GALT | Fusion gene ID: 37964 | Hgene | Tgene | Gene symbol | THAP7 | A4GALT | Gene ID | 80764 | 53947 |
| Gene name | THAP domain containing 7 | alpha 1,4-galactosyltransferase (P blood group) | |
| Synonyms | - | A14GALT|A4GALT1|Gb3S|P(k)|P1|P1PK|PK | |
| Cytomap | 22q11.21 | 22q13.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | THAP domain-containing protein 7 | lactosylceramide 4-alpha-galactosyltransferaseCD77 synthaseGB3 synthaseP blood group (P one antigen)P one antigen (P blood group)P(k) antigen synthaseP1/Pk synthaseUDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferasealpha 14-gal | |
| Modification date | 20180522 | 20180519 | |
| UniProtAcc | Q9BT49 | Q9NPC4 | |
| Ensembl transtripts involved in fusion gene | ENST00000215742, ENST00000399133, | ENST00000401850, ENST00000249005, ENST00000381278, ENST00000465765, | |
| Fusion gene scores | * DoF score | 3 X 2 X 3=18 | 2 X 1 X 2=4 |
| # samples | 3 | 2 | |
| ** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/4*10)=2.32192809488736 | |
| Context | PubMed: THAP7 [Title/Abstract] AND A4GALT [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | THAP7 | GO:0045892 | negative regulation of transcription, DNA-templated | 17577209 |
| Tgene | A4GALT | GO:0007009 | plasma membrane organization | 10747952 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | SKCM | TCGA-FS-A4F4-06A | THAP7 | chr22 | 21354936 | - | A4GALT | chr22 | 43091637 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000215742 | ENST00000401850 | THAP7 | chr22 | 21354936 | - | A4GALT | chr22 | 43091637 | - |
| 5CDS-intron | ENST00000215742 | ENST00000249005 | THAP7 | chr22 | 21354936 | - | A4GALT | chr22 | 43091637 | - |
| 5CDS-intron | ENST00000215742 | ENST00000381278 | THAP7 | chr22 | 21354936 | - | A4GALT | chr22 | 43091637 | - |
| 5CDS-5UTR | ENST00000215742 | ENST00000465765 | THAP7 | chr22 | 21354936 | - | A4GALT | chr22 | 43091637 | - |
| 5CDS-intron | ENST00000399133 | ENST00000401850 | THAP7 | chr22 | 21354936 | - | A4GALT | chr22 | 43091637 | - |
| 5CDS-intron | ENST00000399133 | ENST00000249005 | THAP7 | chr22 | 21354936 | - | A4GALT | chr22 | 43091637 | - |
| 5CDS-intron | ENST00000399133 | ENST00000381278 | THAP7 | chr22 | 21354936 | - | A4GALT | chr22 | 43091637 | - |
| 5CDS-5UTR | ENST00000399133 | ENST00000465765 | THAP7 | chr22 | 21354936 | - | A4GALT | chr22 | 43091637 | - |
Top |
FusionProtFeatures for THAP7_A4GALT |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| THAP7 | A4GALT |
| Chromatin-associated, histone tail-binding protein thatrepresses transcription via recruitment of HDAC3 and nuclearhormone receptor corepressors. {ECO:0000269|PubMed:15561719}. | Necessary for the biosynthesis of the Pk antigen ofblood histogroup P. Catalyzes the transfer of galactose tolactosylceramide and galactosylceramide. Necessary for thesynthesis of the receptor for bacterial verotoxins. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for THAP7_A4GALT |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for THAP7_A4GALT |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| THAP7 | LURAP1, SET, CCDC85B, TRAF2, MDFI, KRTAP4-12, EHMT2, HCFC1, TAF1B, HIST1H3A, HIST1H4A, HDAC3, NCOR1, MAP1LC3B, HINFP, APP, GNAI1, PPP3CC, PELI2, PHC2, GOLGA2, KRT31, PIN1, TRAF1, MID2, MTUS2, CCNDBP1, TFIP11, THAP7, LZTS2, LNX1, KRT40, KRTAP10-8, KRTAP10-3, NOTCH2NL, ZDHHC17, RPL26L1, RPL26, NIP7, ASPM, DDX24, ZNF512, RPL7, CEBPZ, EXOC1, RPS3A, NOP56, RPL13, C7orf50, EBNA1BP2, FBXO11, NOP2, RPS27A, RBM34, KIAA0020, RPL32, RPL13A, RPL18A, NLE1, ASH1L, HIST1H2AG, TRIM26 | A4GALT | ABHD14A, PTGFRN, ICK, FCGRT, ABHD17B, CANX |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for THAP7_A4GALT |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for THAP7_A4GALT |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | A4GALT | C0006413 | Burkitt Lymphoma | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|